How is the Candel Therapeutics Inc today?

The Candel Therapeutics Inc today is trading in the down by -3.46% at 4.75.

How has Candel Therapeutics Inc performed historically?

The Candel Therapeutics Inc is currently trading down -3.46% on an intraday basis in the past week the index fell -7.41%. The index has been down -41.07% in the past quarter and fell -21.36% in the past year. You can view this in the overview section.

What is Candel Therapeutics Inc Annual Net Profit?

Candel Therapeutics Inc Annual Net Profit fell 45.44% in the last year to $55.18 M. Its sector's average net profit growth for the last fiscal year was -12.49%.

What is Candel Therapeutics Inc Price to Earning Ratio?

Candel Therapeutics Inc Price to Earning Ratio is -6.01, which is negative.

What is Candel Therapeutics Inc Stock Price?

Candel Therapeutics Inc Stock Price fell 21.36% and underperformed its sector by 44.85% in the past year.

What is Candel Therapeutics Inc Quarterly Net profit?

Candel Therapeutics Inc Quarterly Net profit rose 189.76% YoY to $7.38 M. Its sector's average net profit growth YoY for the quarter was 10.55%.

What is Candel Therapeutics Inc Debt to Equity Ratio?

Candel Therapeutics Inc Debt to Equity Ratio of 0.2 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Candel Therapeutics Inc Return on Equity(ROE)?

Candel Therapeutics Inc Return on Equity(ROE) for the last financial year was -139.56%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Candel Therapeutics Inc Mutual Fund Holding?

Candel Therapeutics Inc Mutual Fund Holding increased by 1.95% in the last quarter to 27.21.

What is Candel Therapeutics Inc Interest Coverage Ratio?

Candel Therapeutics Inc Interest Coverage Ratio is -25.4, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Candel Therapeutics Inc Institutional Holding?

Candel Therapeutics Inc Institutional Holding increased by 5.59% in the last quarter to 42.37.

MARKETS
SECTOR : COMMERCIAL SERVICES & SUPPLIES
INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
CANDEL THERAPEUTICS INC

Candel Therapeutics Inc XNAS: CADL

Candel Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Candel Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Candel Therapeutics Inc
Rating: 0.97891675
Author: Trendlyne DVM scores

about

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on...

4.75 -0.17 (-3.46%)

67.47% Fall from 52W High

1.1M

XNAS Volume

XNAS 20 Jun, 2025 4:00 PM (EDT)

Board Meeting

The next board meeting for Candel Therapeutics Inc is on 26 Jun 2025 for the purpose of Candel Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

6.2 / 100

Technically Bearish

33.0 / 100

No estimates available

Candel Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Candel Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on...

67.47% Fall from 52W High

SWOT Analysis

Candel Therapeutics Inc Live Price Chart

Candel Therapeutics Inc FAQ

How is Candel Therapeutics Inc today?

Candel Therapeutics Inc today is trading in the red, and is down by -3.46% at 4.75.

How has Candel Therapeutics Inc performed historically?

Candel Therapeutics Inc is currently trading down -3.46% on an intraday basis. In the past week the stock fell -7.41%. stock has been down -41.07% in the past quarter and fell -21.36% in the past year. You can view this in the overview section.